Date:January 11, 2026
Bio Usawa will participate in the 44th J.P. Morgan Healthcare Conference, taking place January 12–15, in San Francisco. The annual conference convenes global healthcare leaders, investors, and partners to engage on the future of healthcare and life sciences.
Bio Usawa is pioneering the development and manufacturing of biologics in Africa, addressing longstanding gaps in supply, infrastructure, and access across the continent and beyond.
Members of the company’s senior leadership, including CEO and President, Dr. Menghis Bairu, will be available for meetings and discussions throughout the conference.
Organizations and partners interested in learning more about Bio Usawa’s mission to strengthen biologics manufacturing and delivery in emerging markets are encouraged to connect with the team.
Schedule a meeting: [email protected]
Bio Usawa Biotechnology Ltd. (Bio Usawa, Inc.) today announced that the Ghana Food and Drugs Authority (Ghana FDA) has approved BioUcenta™, a biosimilar…
January 2026The successful initial qualification of Bio Usawa's proprietary modular biomanufacturing platform, BioMod™, marks a major step forward in building scala…
January 2026The initial qualification of our proprietary modular manufacturing platform (BioMod™) marks a turning point toward scalable, cost-effective biologics ma…
January 2026